Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells.

  • Authors:
    • K Nishio
    • K Fukuoka
    • H Fukumoto
    • T Sunami
    • Y Iwamoto
    • T Suzuki
    • J Usuda
    • N Saijo
  • View Affiliations

  • Published online on: March 1, 1999     https://doi.org/10.3892/ijo.14.3.461
  • Pages: 461-470
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Mitogen-activated protein kinase (MAPK) pathway is proposed to be a therapeutic target for cancer cells. In order to find the potential therapeutic usefulness of MAPK for cancer cells, the effect of EAS1, an antisense oligonucleotide for an MAPK, on cancer-cell-growth were investigated in vitro. EAS1 effectively inhibited the growth of several human lung cancer cell lines such as PC-14 cells upon exposure to 10-0-10-1 microM of EAS1 determined dye-formation (MTT) assay. The ED50 values were comparable to those obtained for the inhibition of MAPK activity, DNA synthesis. EAS1 arrested the PC-14 cells at the G2/M phase of cell cycle followed by apoptosis in a dose-dependent manner. In order to determine the factors which influence the cellular sensitivity against MAPK inhibition, the effect of EAS1 on H-ras-transformed murine fibroblast cells were compared with that on parental cells. The NIH3T3 cells transformed by the H-ras gene (PT22-3) showed higher sensitivity against the effects of EAS1. Because MAPK activity was activated by H-ras gene transfection in PT22-3, the status of the MAPK cascade in cells was the determining factor for the efficacy of EAS1. In addition, cell permeabilization by digitonin enhanced the growth inhibitory effect of EAS1. Penetration of the cell membrane by EAS1 is also crucial for the growth inhibitory effect of EAS1. In conclusion, MAPK is an important target for cancer treatment and MAPK antisense oligonucleotide is a potentially significant antitumor oligonucleotide.

Related Articles

Journal Cover

Mar 1999
Volume 14 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Nishio K, Fukuoka K, Fukumoto H, Sunami T, Iwamoto Y, Suzuki T, Usuda J and Saijo N: Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells.. Int J Oncol 14: 461-470, 1999.
APA
Nishio, K., Fukuoka, K., Fukumoto, H., Sunami, T., Iwamoto, Y., Suzuki, T. ... Saijo, N. (1999). Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells.. International Journal of Oncology, 14, 461-470. https://doi.org/10.3892/ijo.14.3.461
MLA
Nishio, K., Fukuoka, K., Fukumoto, H., Sunami, T., Iwamoto, Y., Suzuki, T., Usuda, J., Saijo, N."Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells.". International Journal of Oncology 14.3 (1999): 461-470.
Chicago
Nishio, K., Fukuoka, K., Fukumoto, H., Sunami, T., Iwamoto, Y., Suzuki, T., Usuda, J., Saijo, N."Mitogen-activated protein kinase antisense oligonucleotide inhibits the growth of human lung cancer cells.". International Journal of Oncology 14, no. 3 (1999): 461-470. https://doi.org/10.3892/ijo.14.3.461